New combination treatment shows promise in kidney cancer
Results from a phase I clinical trial with a combination [...]
Results from a phase I clinical trial with a combination [...]
Results from the IMmotion150 phase II clinical trial showed that [...]
The measurement of immune-inflammation index, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio [...]
Interim results from Study 111, a phase Ib/II clinical trial [...]
Ipsen and Exelixis have announced updated results from the phase 2 [...]
Bristol-Myers Squibb (BMS) has reported positive phase 3 results for its clinical [...]
The following blog from Mesothelioma.net gives a good summary of [...]
New immunotherapy treatments are currently revolutionising the field of oncology [...]
Robot assisted surgery (RAS) is becoming more widely used in [...]
Tivozanib (Fotivda) has been approved by the European Commission (EC) [...]